Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: Results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM). Rachel Galot,Christophe Le Tourneau, Lisa F. Licitra,Amaury Daste,Caroline Even,Esma Saada-Bouzid,Stephanie Henry,Sylvie Rottey,Emmanuel Seront, Marie-Christine Kaminsky,Sylvie Zanetta, Annemie Rutten,Neus Baste,Philip R. Debruyne, Jeremy Leys, Konstantina Tsechilidou, Catherine Fortpied, Sandrine Marreaud, Anne-Sophie Govaerts,Jean-Pascal H. MachielsJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
